- Home
- TLSA vs CCG Comparison
TLSA vs CCG Comparison
Compare TLSA & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- CCG
- Stock Information
- Founded
- TLSA 2013
- CCG 2014
- Country
- TLSA United Kingdom
- CCG China
- Employees
- TLSA N/A
- CCG N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- CCG
- Sector
- TLSA Health Care
- CCG
- Exchange
- TLSA Nasdaq
- CCG Nasdaq
- Market Cap
- TLSA 240.0M
- CCG 82.9M
- IPO Year
- TLSA 2000
- CCG N/A
- Fundamental
- Price
- TLSA $1.94
- CCG $1.01
- Analyst Decision
- TLSA
- CCG Buy
- Analyst Count
- TLSA 0
- CCG 1
- Target Price
- TLSA N/A
- CCG $350.00
- AVG Volume (30 Days)
- TLSA 336.7K
- CCG 233.9K
- Earning Date
- TLSA 05-06-2025
- CCG 11-25-2025
- Dividend Yield
- TLSA N/A
- CCG N/A
- EPS Growth
- TLSA N/A
- CCG N/A
- EPS
- TLSA N/A
- CCG N/A
- Revenue
- TLSA N/A
- CCG $444,290,042.00
- Revenue This Year
- TLSA N/A
- CCG N/A
- Revenue Next Year
- TLSA N/A
- CCG $15.80
- P/E Ratio
- TLSA N/A
- CCG N/A
- Revenue Growth
- TLSA N/A
- CCG N/A
- 52 Week Low
- TLSA $0.63
- CCG $0.71
- 52 Week High
- TLSA $2.60
- CCG $1.54
- Technical
- Relative Strength Index (RSI)
- TLSA 47.55
- CCG 42.02
- Support Level
- TLSA $1.81
- CCG $0.95
- Resistance Level
- TLSA $2.04
- CCG $1.04
- Average True Range (ATR)
- TLSA 0.18
- CCG 0.07
- MACD
- TLSA -0.03
- CCG -0.01
- Stochastic Oscillator
- TLSA 25.00
- CCG 23.08
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.